Długoterminowe wyniki leczenia padaczki u pacjentów z oporną na leki padaczką skroniową z zanikem hipokampa

PubMed➕ 04.08.2026Clin Neurol Neurosurg

Long-term seizure outcomes in patients with drug-resistant mesial temporal lobe epilepsy due to hippocampal sclerosis

W skrócie

Badanie dotyczy pacjentów z trudną do leczenia padaczką, u których usunięto chirurgicznie zmienioną część mózgu. Przez ponad 10 lat obserwacji aż 62% pacjentów osiągnęło pełną kontrolę napadów, a ponadto zaobserwowano poprawę pamięci i funkcji poznawczych. Wyniki sugerują, że wczesne skierowanie do chirurgii powinno być ważnym etapem leczenia w przypadku opornej na leki padaczki skroniowej.

Oryginalny abstract (angielski)

OBJECTIVE: Resective surgery is a significant therapeutic option for patients with drug-resistant mesial temporal lobe epilepsy (MTLE) due to hippocampal sclerosis (HS). Numerous studies have demonstrated the efficacy of epilepsy surgery in the short to median term. However, studies on long-term outcomes are limited in number. The objective of this study was to document the long-term prognosis and associated factors of patients undergoing resective surgery for MTLE. METHODS: A retrospective analysis was conducted on the data of patients with drug-resistant MTLE due to HS who underwent resective surgery between 2001 and 2013 at our epilepsy centre. The demographics and clinical variables of the patients were documented and analysed in order to ascertain their long-term prognosis. The postoperative outcomes were evaluated in accordance with the Engel classification system. RESULTS: Of the 45 patients (mean age: 44.64 ± 8.96, range: 31-67), 31 (68.89%) were male. The age at onset of epilepsy, age at surgery, and the duration of epilepsy at the time of surgery ranged from 0.25 to 26 years (11.51 ± 7.07), from 12 to 47 years (26.82 ± 8.14), and from 2 to 33 years (16.03 ± 7.85), respectively. The patients were followed up for 10-23 years (17.73 ± 2.96). HS was identified in 23 (51.11%) of the patients on the right side and 22 (48.89%) on the left. The pre-operative EEG recordings revealed temporal discharges in 40 (88.89%) patients unilaterally. 22 patients (48.89%) underwent amygdalohippocampectomy with a temporal lobectomy (AH+ATL), while 23 patients (51.11%) underwent selective amygdalohippocampectomy (SAH). 28 (62.22%) patients were classified as Engel I. The patients did not have any statistically significant difference in terms of gender, age at epilepsy onset, age at surgery, duration of epilepsy at surgery, side of HS, and surgical procedure according to Engel classification (p = 0.64, 0.08, 0.60, 0.25, 0.67, 0.10, respectively). Executive and memory functions were improved after surgery at 5th year. CONCLUSION: 62% of the patients were classified as Engel I. Although previous studies have suggested that certain factors may influence prognosis, our findings did not yield any statistically significant results in this regard. It is crucial that patients undergo surgical evaluation without delay to achieve seizure control and improve cognitive function.

Metadane publikacji

Journal
Clin Neurol Neurosurg
Data publikacji
30.07.2026
PMID
42546600
DOI
10.1016/j.clineuro.2026.109599
Autorzy
Gül G, Eren F, Yılmaz MK, Kuşcu DY, Keskinkılıç C, Tuğcu B
Słowa kluczowe
Drug-resistant seizures, Epilepsy surgery, Hippocampal sclerosis, Long-term follow-up, Mesial temporal lobe epilepsy
Źródło
PubMed